Symbol
| RNF213
| contributors: mct - updated : 02-12-2016
|
HGNC name
| ring finger protein 213
|
HGNC id
| 14539
|
corresponding disease(s)
|
MYMY2
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| fusion
|  
|  
|  
|
used to ALK in an ALCL (ALK-positive anaplastic large-cell lymphoma) case with a t(2;17)(p23;q25) | constitutional
|  
|  
| --over
|  
|
in the ischemic brain | constitutional
|  
|  
|  
| loss of function
|
improved glucose tolerance by protecting islet beta cells | |
Susceptibility
|
to Moyamoya disease (see MYMY4) to Intracranial aneurysms (IAs) to intracranial major artery stenosis/occlusion (ICASO) |
Variant & Polymorphism
other
| R4810K polymorphism increases susceptibility to Moyamoya disease, inducing phenotypes associated with mitotic abnormalities |
|
SNP rs6565666 appeared to be significantly associated with IA subjects |
|
RNF213 c.14576G>A is a susceptibility gene for intracranial major artery stenosis/occlusion (ICASO) |
|
|
Candidate gene
Marker
Therapy target
| | | |
| knockdown of Rnf213 in zebrafish caused irregular wall formation in trunk arteries and abnormal sprouting vessels | |
increased vascular expression of Mmp9 and subsequent vascular wall thinning in Rnf213-/- mice could reflect the early characteristic of MMD (Moyamoya disease) |
|
|